| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |